MiRNA polymorphisms affect the prognosis of gastric cancer: insights from Xianyou, Fujian.
作者信息
Wu Ping, Zhang Yuling, Lyu Yanping, Chen Jingwen, Jiang Yu, Xiang Jianjun, Liu Baoying, Wu Chuancheng
机构信息
Department of Preventive Medicine, School of Public Health, Fujian Medical University, Fuzhou, China.
Department of Pulmonary and Critical Care Medicine, Fujian Medical University Union Hospital, Fuzhou, Fujian, China.
出版信息
Front Oncol. 2024 May 15;14:1355270. doi: 10.3389/fonc.2024.1355270. eCollection 2024.
INTRODUCTION
Gastric cancer, characterized by high incidence and substantial disease burden, has drawn continuous attention regarding its occurrence and prognosis. Genetics plays a crucial role in influencing the prognosis of gastric cancer, and single nucleotide polymorphisms are closely associated with the occurrence, development, and prognosis of this malignant tumor. Our study aims to conduct survival analysis on patients carrying different single nucleotide polymorphisms, exploring the relationship between miRNA single nucleotide polymorphisms and the prognosis of gastric cancer.
METHODS
Genetic data from 344 patients in Xianyou, Fujian, formed the basis of our study. We delineated the survival rate and median survival time, utilizing the log-rank test and COX regression analysis as statistical tools.
RESULTS
Upon stratifying the data by sex or operation, it was discerned that the GG genotype at MSH2 rs17502941 independently posed a heightened risk for gastric cancer. Other stratification analyses suggested that the subsequent single nucleotide polymorphisms were correlated with patient prognosis: rs17502941, rs884225, rs1468063, rs7143252, and rs2271738.
DISCUSSION
The outcomes of this study strongly suggest that miRNA polymorphisms significantly influence the survival time of gastric cancer patients and can serve as effective predictors for the prognosis of gastric cancer.
相似文献
World J Surg Oncol. 2022-8-31
Zhonghua Yu Fang Yi Xue Za Zhi. 2011-8
本文引用的文献
Asian Pac J Cancer Prev. 2023-6-1
Asian Pac J Cancer Prev. 2023-6-1
N Engl J Med. 2023-3-30
Nat Rev Clin Oncol. 2023-5
Genet Test Mol Biomarkers. 2022-10
Int J Mol Sci. 2021-4-4